{"id":"https://openalex.org/W1976604689","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-15","title":"Abstract P6-12-15: Preclinical testing of a novel platelet derived growth factor receptor alpha (PDGFRa) inhibitor in inflammatory breast cancer","display_name":"Abstract P6-12-15: Preclinical testing of a novel platelet derived growth factor receptor alpha (PDGFRa) inhibitor in inflammatory breast cancer","publication_year":2013,"publication_date":"2013-12-15","ids":{"openalex":"https://openalex.org/W1976604689","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-15","mag":"1976604689"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs13-p6-12-15","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-15","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-15","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110349658","display_name":"M Joglekar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115489","display_name":"Arog Pharmaceuticals (United States)","ror":"https://ror.org/01rgp0j22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115489"]},{"id":"https://openalex.org/I86501945","display_name":"University of Delaware","ror":"https://ror.org/01sbq1a82","country_code":"US","type":"education","lineage":["https://openalex.org/I86501945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Joglekar","raw_affiliation_strings":["University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","AROG Pharmaceuticals, Dallas, TX","University of Delaware, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I86501945"]},{"raw_affiliation_string":"AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I4210115489"]},{"raw_affiliation_string":"University of Delaware, Newark, DE","institution_ids":["https://openalex.org/I86501945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077531941","display_name":"Steven Van Laere","orcid":"https://orcid.org/0000-0002-2640-0040","observed_orcids":["https://orcid.org/0000-0002-2640-0040"]},"institutions":[{"id":"https://openalex.org/I4210115489","display_name":"Arog Pharmaceuticals (United States)","ror":"https://ror.org/01rgp0j22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115489"]},{"id":"https://openalex.org/I86501945","display_name":"University of Delaware","ror":"https://ror.org/01sbq1a82","country_code":"US","type":"education","lineage":["https://openalex.org/I86501945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Van Laere","raw_affiliation_strings":["University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","AROG Pharmaceuticals, Dallas, TX","University of Delaware, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I86501945"]},{"raw_affiliation_string":"AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I4210115489"]},{"raw_affiliation_string":"University of Delaware, Newark, DE","institution_ids":["https://openalex.org/I86501945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108456467","display_name":"P Vermeulen","orcid":"https://orcid.org/0009-0006-2254-5134","observed_orcids":["https://orcid.org/0009-0006-2254-5134"]},"institutions":[{"id":"https://openalex.org/I4210115489","display_name":"Arog Pharmaceuticals (United States)","ror":"https://ror.org/01rgp0j22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115489"]},{"id":"https://openalex.org/I86501945","display_name":"University of Delaware","ror":"https://ror.org/01sbq1a82","country_code":"US","type":"education","lineage":["https://openalex.org/I86501945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P Vermeulen","raw_affiliation_strings":["University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","AROG Pharmaceuticals, Dallas, TX","University of Delaware, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I86501945"]},{"raw_affiliation_string":"AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I4210115489"]},{"raw_affiliation_string":"University of Delaware, Newark, DE","institution_ids":["https://openalex.org/I86501945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022173747","display_name":"Luc Yves Dirix","orcid":"https://orcid.org/0000-0002-7792-9964","observed_orcids":["https://orcid.org/0000-0002-7792-9964"]},"institutions":[{"id":"https://openalex.org/I4210115489","display_name":"Arog Pharmaceuticals (United States)","ror":"https://ror.org/01rgp0j22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115489"]},{"id":"https://openalex.org/I86501945","display_name":"University of Delaware","ror":"https://ror.org/01sbq1a82","country_code":"US","type":"education","lineage":["https://openalex.org/I86501945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Dirix","raw_affiliation_strings":["University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","AROG Pharmaceuticals, Dallas, TX","University of Delaware, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I86501945"]},{"raw_affiliation_string":"AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I4210115489"]},{"raw_affiliation_string":"University of Delaware, Newark, DE","institution_ids":["https://openalex.org/I86501945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028772847","display_name":"Monique Carter","orcid":"https://orcid.org/0000-0002-2749-9513","observed_orcids":["https://orcid.org/0000-0002-2749-9513"]},"institutions":[{"id":"https://openalex.org/I4210115489","display_name":"Arog Pharmaceuticals (United States)","ror":"https://ror.org/01rgp0j22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115489"]},{"id":"https://openalex.org/I86501945","display_name":"University of Delaware","ror":"https://ror.org/01sbq1a82","country_code":"US","type":"education","lineage":["https://openalex.org/I86501945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Carter","raw_affiliation_strings":["University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","AROG Pharmaceuticals, Dallas, TX","University of Delaware, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I86501945"]},{"raw_affiliation_string":"AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I4210115489"]},{"raw_affiliation_string":"University of Delaware, Newark, DE","institution_ids":["https://openalex.org/I86501945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043283652","display_name":"A Rhamchandran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115489","display_name":"Arog Pharmaceuticals (United States)","ror":"https://ror.org/01rgp0j22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115489"]},{"id":"https://openalex.org/I86501945","display_name":"University of Delaware","ror":"https://ror.org/01sbq1a82","country_code":"US","type":"education","lineage":["https://openalex.org/I86501945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Rhamchandran","raw_affiliation_strings":["University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","AROG Pharmaceuticals, Dallas, TX","University of Delaware, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I86501945"]},{"raw_affiliation_string":"AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I4210115489"]},{"raw_affiliation_string":"University of Delaware, Newark, DE","institution_ids":["https://openalex.org/I86501945"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075994170","display_name":"Kenneth van Golen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115489","display_name":"Arog Pharmaceuticals (United States)","ror":"https://ror.org/01rgp0j22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115489"]},{"id":"https://openalex.org/I86501945","display_name":"University of Delaware","ror":"https://ror.org/01sbq1a82","country_code":"US","type":"education","lineage":["https://openalex.org/I86501945"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"KL van Golen","raw_affiliation_strings":["University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","AROG Pharmaceuticals, Dallas, TX","University of Delaware, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Delaware, Newark, DE; Translational Cancer Research Unit, Antwerp, Belgium; AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I86501945"]},{"raw_affiliation_string":"AROG Pharmaceuticals, Dallas, TX","institution_ids":["https://openalex.org/I4210115489"]},{"raw_affiliation_string":"University of Delaware, Newark, DE","institution_ids":["https://openalex.org/I86501945"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"24_Supplement","first_page":"P6","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5238999724388123,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5238999724388123,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.3440000116825104,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-breast-cancer","display_name":"inflammatory breast cancer","score":1.0},{"id":"https://openalex.org/keywords/pdgfra","display_name":"PDGFRA","score":0.75},{"id":"https://openalex.org/keywords/crenolanib","display_name":"crenolanib","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pdgfr-inhibitors","display_name":"PDGFR inhibitors","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tumor-emboli","display_name":"tumor emboli","score":0.6970000267028809},{"id":"https://openalex.org/keywords/dermal-lymphatic-vessels","display_name":"dermal lymphatic vessels","score":0.7609999775886536},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8029999732971191},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.75},{"id":"https://openalex.org/keywords/constitutive-receptor-activation","display_name":"constitutive receptor activation","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.7367426156997681},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6711891889572144},{"id":"https://openalex.org/C2780839634","wikidata":"https://www.wikidata.org/wiki/Q5922406","display_name":"Inflammatory breast cancer","level":4,"score":0.6404085755348206},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6298130750656128},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.5967664122581482},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5278159379959106},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5246358513832092},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.5185006856918335},{"id":"https://openalex.org/C2781294074","wikidata":"https://www.wikidata.org/wiki/Q22327352","display_name":"Platelet-derived growth factor","level":5,"score":0.4461096227169037},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3927821218967438},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.37975436449050903},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3593386709690094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29028958082199097},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.0},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs13-p6-12-15","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-15","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-15","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2623655675","https://openalex.org/W2565287092","https://openalex.org/W2977933313","https://openalex.org/W3017960842","https://openalex.org/W2316531882","https://openalex.org/W2804476031","https://openalex.org/W2082405575","https://openalex.org/W2330171122","https://openalex.org/W2145934373","https://openalex.org/W4393095966"],"abstract_inverted_index":{"Abstract":[0,337],"Inflammatory":[1],"breast":[2,13],"cancer":[3,14],"(IBC)":[4],"is":[5,46,55,80,120,156,170,178,198,311,321],"the":[6,35,40,43,49,112,140,162,168,222,243,247,301],"most":[7],"lethal":[8],"form":[9],"of":[10,39,164,246,287,296],"locally":[11],"advanced":[12],"and":[15,30,67,148,159,206,270,318,324],"carries":[16],"a":[17,23,56,188,236,253,284,292,312,322],"guarded":[18],"prognosis.":[19],"IBC":[20,54,89,105,125,145,165,203,214,257,266,274,288,316,329],"presents":[21],"with":[22,226,232,291],"\u201clumpless\u201d":[24],"primary":[25],"tumor,":[26],"which":[27,193],"rapidly":[28],"infiltrates":[29],"forms":[31],"tumor":[32,204,240,267],"emboli":[33,258,268],"within":[34],"dermal":[36],"lymphatic":[37],"vessels":[38],"skin":[41],"overlying":[42],"breast.":[44],"It":[45],"clear":[47],"from":[48],"recent":[50],"research":[51],"advancements":[52],"that":[53,111,154,187,263,309,319],"unique":[57],"entity,":[58],"not":[59,217],"only":[60],"in":[61,73,88,124,144,161,219,239,255,315],"its":[62,74],"clinical":[63],"presentation,":[64],"disease":[65],"progression":[66],"response":[68],"to":[69,82,91,96,100,131,200,272,276,282,300],"therapy":[70],"but":[71],"also":[72],"molecular":[75,85],"expression":[76,86],"profile.":[77],"Therefore,":[78],"it":[79],"essential":[81],"carry":[83],"out":[84],"studies":[87],"compared":[90,130,299],"non-IBC":[92,132],"as":[93,95],"well":[94],"pursue":[97],"these":[98,306],"differences":[99],"study":[101],"their":[102],"effects":[103],"on":[104],"phenotype.":[106],"Our":[107,151],"laboratory":[108],"has":[109],"demonstrated":[110,235],"platelet":[113],"derived":[114],"growth":[115,205,241,259],"factor":[116],"receptor":[117,169],"alpha":[118],"(PDGFRa)":[119],"significantly":[121,201],"over":[122,242],"expressed":[123],"patient":[126,133,146],"samples":[127,147],"(between":[128],"15-36%)":[129],"samples.":[134],"Using":[135],"multiple":[136],"approaches":[137],"we":[138,185,261],"demonstrate":[139,262,308],"PDGFR\u03b1":[141,155,172,177,310],"activation":[142],"signature":[143],"cell":[149,289],"lines.":[150],"data":[152,307],"demonstrates":[153],"constitutively":[157],"active":[158,196],"localized":[160],"cytoplasm":[163],"cells.":[166,330],"Although":[167],"intracellular,":[171],"signaling":[173],"remains":[174],"intact.":[175],"Thus,":[176],"an":[179],"attractive":[180],"target":[181,314],"for":[182],"therapy.":[183],"Here":[184],"show":[186],"novel":[189,254],"PDGFR":[190],"inhibitor,":[191],"crenolanib,":[192],"specifically":[194],"targets":[195],"PDGFR,":[197],"able":[199,281],"inhibit":[202],"progression.":[207],"In":[208,228,249],"nude":[209],"mice,":[210],"200":[211],"mm3":[212],"orthotopic":[213],"tumors":[215],"did":[216],"increase":[218,238],"size":[220],"when":[221],"mice":[223,230],"were":[224,280],"treated":[225,231],"crenolanib.":[227],"contrast,":[229],"vehicle":[233],"control":[234],"4-fold":[237],"2-week":[244],"course":[245],"experiment.":[248],"addition,":[250],"by":[251,303],"using":[252],"vitro":[256],"model,":[260],"crenolanib":[264,320],"prevents":[265],"formation":[269],"acts":[271],"sensitize":[273],"cells":[275],"chemotherapeutic":[277,297],"agents.":[278],"We":[279],"achieve":[283],"similar":[285],"level":[286],"killing":[290],"10-fold":[293],"lower":[294],"dose":[295],"agents":[298,302],"themselves.":[304],"Together,":[305],"viable":[313],"patients":[317],"potent":[323],"effective":[325],"therapeutic":[326],"agent":[327],"against":[328],"Citation":[331],"Information:":[332],"Cancer":[333],"Res":[334],"2013;73(24":[335],"Suppl):":[336],"nr":[338],"P6-12-15.":[339]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}